FDA.reportPublic FDA data

FD&C GREEN NO. 3

Substance profile for UNII 3P3ONR6O1S, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
3P3ONR6O1S
Preferred term
FD&C GREEN NO. 3
Registry number
2353-45-9
Ingredient type
INGREDIENT SUBSTANCE

Chemical And Database Identifiers#

RxCUI
0
PubChem
0
NCIt
C71676
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
NCI ThesaurusC71676ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71676
FDA Substance Registration System3P3ONR6O1Sprecision.fda.gov/uniisearch/srs/unii/3P3ONR6O1S

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
DRUG FACTS2
075dbfb1-47c2-4578-a212-f8e656f0e9f92
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
85e15203-6d84-4361-877a-7342f070b9381
Indomethacin Extended – Release Capsules, USP 75 mg5
These highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for Prevacid: PREVACID (lansoprazole) delayed-release capsules, for oral use PREVACID SoluTab (lansoprazole) delayed-release orally disintegrating tablets, for oral use Initial U.S. Approval: 19951000
DRUG FACTS1
Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.5
Morphine Sulfate Extended-release Capsules, USP Revised: May 2011 CII Rx only 1985282
e17c57fa-d99d-4cd4-ba1e-b58e30092b482
Drug Facts2
Drug Facts1
Colgate ® Total ® Advanced Pro-Shield™ Mouthwash Spearmint Surge™1
TEMAZEPAM CAPSULES, USP CIV 40-9177 Revised – June 2012 Rx only2
HydrOXYzine Pamoate Capsules USP, 25 mg and 50 mg R x only1
CEPHALEXIN CAPSULES USP2
Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.3
whole health Hand Sanitizers Kit1
These highlights do not include all the information needed to use duloxetine delayed-release capsules USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules USP. DULOXETINE delayed-release capsules USP for oral use Initial U.S. Approval: 20042
DILTIAZEM HYDROCHLORIDE Extended-release Capsules, USP1001
f1f051d8-b8d8-4afd-84d8-82a59d9fa4fb1
These highlights do not include all the information needed to use Omeprazole delayed-release capsules safely and effectively. See full prescribing information for Omeprazole delayed-release capsules. OMEPRAZOLE delayed-release capsules, USP, for oral use Initial U.S. Approval: 198923
718b6ebd-279e-4de0-ad46-c1d2a25ed19d2
Hydroxyzine Pamoate Capsules USP 25 mg10
Rx Only2
Dial Aloe1
Diltiazem hydrochloride Extended Release Capsules1
8a97d303-a061-4e5d-b963-8efb4aaaac091
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
Oral Dent Fresh Mint2
Oral Dent Blue Mint2
Buenos Dias de Personna cool mint1
Buenos Dias de Personna mint1
Oral Dent Blue Mint1
Oral Dent Fresh Mint1
DRUG FACTS1
DRUG FACTS1
METHYLPHENIDATE HYDROCHLORIDE TABLETS, USP CII9
Hydroxyzine Pamoate Capsules USP1
Foaming Antiseptic Hand Cleaner1
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP1
DILTIAZEM HYDROCHLORIDE Extended-release Capsules, USP1
ZALEPLON CAPSULES CIV 5268 5269 Rx only2
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.1
Chlordiazepoxide HCl/ Clidinium Bromide CAPSULES2
DRUG FACTS1
These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-release Capsules, USP INITIAL U.S. APPROVAL: 19891
Inflammation Therapy1
Drug Facts1
CEPHALEXIN CAPSULES USP2
c70b5045-706e-443a-9be1-d0bc3c5981304
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
DRUG FACTS1
fc39b8dd-a4bd-4b40-accf-edd248a0b4fa1
Hydroxyzine Pamoate Capsules USP3
PIROXICAM CAPSULES USP 0756 0757 Rx only4
Colgate ® Sparkling WH ® Mint Zing 2.8ozFluoride Toothpaste2
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP (Once-a-Day Dosage) Rx Only4
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP6
DRUG FACTS1
Walgreen Co. Nighttime Cold & Flu Relief Drug Facts2
Hydroxyzine Pamoate Capsules USP1
DRUG FACTS1
CEPHALEXIN CAPSULES USP2
Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.3
7c149887-b375-46d4-ac78-4f838464111e2
Meijer Distribution, Inc. Nite Time Cold & Flu Drug Facts2
DEXAMETHASONE Tablets USP,1
TEMAZEPAM CAPSULES, USP CIV1
AMRIX ® (Cyclobenzaprine Hydrochloride Extended-Release Capsules)3
Oxybutynin Chloride Syrup USP2
INDOMETHACIN CAPSULES USP Rx only1
DRUG FACTS1
b3180408-a3c0-4e02-8535-dea390a522777
Chlordiazepoxide HCl and Clidinium Bromide Capsules1
Zaleplon Capsules CIV1
d4569486-e581-4671-b32c-1903abfa726e1
PIROXICAM CAPSULES USP 0756 0757 Rx only2
PIROXICAM 20 MG CAPSULES Rx Only1
These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 19893
Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.1
CEFDINIR CAPSULES 3160 Rx only1
Drug Fact1
ca5fa172-fd4a-4498-a88a-3265c54683841
DRUG FACTS1
Colgate ® Sparkling White ® Mint Zing Fluoride Toothpaste1
CEPHALEXIN CAPSULES USP3
These highlights do not include all the information needed to use Vyvanse safely and effectively. See full prescribing information for Vyvanse. Vyvanse ® (lisdexamfetamine dimesylate) Capsules, CII Initial U.S. Approval: 20074
Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.2
These highlights do not include all the information needed to use Lansoprazole Delayed-Release Capsules and Lansoprazole Delayed-Release Orally Disintegrating Tablets safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules Lansoprazole Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 19952
Indomethacin Extended – Release Capsules, USP 75 mg3231
DRUG FACTS1
4e9b122b-eddf-42d3-aeae-bee38badb2d52
These highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules, 0.4 mg Initial U.S. Approval: 19973
4a7c04dc-7d51-4b98-aa1c-19f30c63d1f32
Therafeldamine8
INDOMETHACIN CAPSULES USP Rx only2
DRUG FACTS1
Cephalexin Capsule2
CEPHALEXIN CAPSULES USP2
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES, USP2
DRUG FACTS1
DRUG FACTS1
b8ca1d80-6ea9-4a3f-ab06-beedf845de8f1
These highlights do not include all the information needed to use Morphine Sulfate Oral Solution and Morphine Sulfate Tablets safely and effectively. See full prescribing information for Morphine Sulfate Oral Solution and Morphine Sulfate Tablets. Initial U.S. Approval: 19841
Drug Facts1
Ketoprofen1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 3P3ONR6O1S page 1 of 1 · 15 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
FD&C GREEN NO. 33P3ONR6O1S2353459GELDENTALNA
FD&C GREEN NO. 33P3ONR6O1S2353459CAPSULEORAL40 mg
FD&C GREEN NO. 33P3ONR6O1S2353459CAPSULE, COATED PELLETSORALNA
FD&C GREEN NO. 33P3ONR6O1S2353459CAPSULE, DELAYED RELEASEORAL5 mg
FD&C GREEN NO. 33P3ONR6O1S2353459CAPSULE, EXTENDED RELEASEORAL0.16 mg
FD&C GREEN NO. 33P3ONR6O1S2353459CAPSULE, LIQUID FILLEDORAL0.03 mg
FD&C GREEN NO. 33P3ONR6O1S2353459ELIXIRORALNA
FD&C GREEN NO. 33P3ONR6O1S2353459SOLUTIONORAL0.25 mg/5ml
FD&C GREEN NO. 33P3ONR6O1S2353459SYRUPORAL3.75 mg/5ml
FD&C GREEN NO. 33P3ONR6O1S2353459TABLETORAL240 mg
FD&C GREEN NO. 33P3ONR6O1S2353459TABLET, COATEDORAL0.01 mg
FD&C GREEN NO. 33P3ONR6O1S2353459TABLET, DELAYED RELEASEORALNA
FD&C GREEN NO. 33P3ONR6O1S2353459SUPPOSITORYRECTAL0.02 mg
FD&C GREEN NO. 33P3ONR6O1S2353459SHAMPOOTOPICAL0.09 %w/w
FD&C GREEN NO. 33P3ONR6O1S2353459SOLUTIONTOPICALNA